trending Market Intelligence /marketintelligence/en/news-insights/trending/S_sLNryjNHCqUobk1hlfbg2 content esgSubNav
In This List

Medtronic's neurosurgery guidance system receives US FDA clearance

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Medtronic's neurosurgery guidance system receives US FDA clearance

The U.S. Food and Drug Administration has cleared Medtronic PLC's Stealth Autoguide system, a robotic surgery platform that provides positioning assistance during neurosurgical procedures.

Medtronic's robotic platform helps surgeons prepare and carry out precise procedures as part of the company's Surgical Synergy platform.

Dublin-based Medtronic develops device-based medical therapies.